Skadden is co-counsel to Tobira Therapeutics, Inc. in its acquisition by Allergan plc for a total potential consideration of up to $1.695 billion.
Skadden, Arps, Slate, Meagher & Flom LLP and Affiliates
Skadden is co-counsel to Tobira Therapeutics, Inc. in its acquisition by Allergan plc for a total potential consideration of up to $1.695 billion.